1-哌嗪戊醇 | 5625-65-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 中文名称: 1-哌嗪戊醇
• 中文别名: 9-羟基-7-(2-羟基苯基)-8H-[1,3]二噁唑并[4,5-g]色烯-8-酮
• 英文名称: 1-(5-hydroxypentyl)piperazine
• 英文别名: 1-(5-Hydroxypentyl)piperazin；N-(ω-Hydroxyamyl)>-piperazin；N-(5-Hydroxy-1-pentyl)piperazin；5-piperazin-1-yl-pentan-1-ol；5-piperazin-1-ylpentan-1-ol
• CAS: 5625-65-0
• 化学式: C₉H₂₀N₂O
• 分子量: 172.271
• InChiKey: JQOBQNAVHUEQPB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  12
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  35.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-哌嗪戊醇 在 sodium carbonate 、 三苯基膦 、 偶氮二甲酸二乙酯 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 生成 2-(4-(5-(4-ethoxyphenoxy)pentyl)piperazin-1-yl)thiazole
  参考文献：
  名称：

  作为人类肠道病毒 71 和柯萨奇病毒 A16 抑制剂的新型取代杂芳族哌嗪和哌啶衍生物

  摘要：

  根据人肠道病毒71衣壳蛋白VP1的结构，通过虚拟筛选发现了一系列取代的杂芳族哌嗪和哌啶衍生物。初步生物学评价表明，化合物 8e 和 9e 对 EV71 和柯萨奇病毒 A16 具有强活性，且细胞毒性较低。

  DOI：

  10.3390/molecules18055059
• 作为产物：
  描述：

  tert-butyl 4-(5-methoxy-5-oxopentyl)piperazine-1-carboxylate 在 盐酸 、 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 二氯甲烷 为溶剂， 生成 1-哌嗪戊醇
  参考文献：
  名称：

  Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. Synthesis and structure-relationships of α,α-tetrahydropyranylglycine

  摘要：

  A series of alpha,alpha-cycloalkylglycine sulfonamide compounds of general formula 1 has previously been identified by our group as selective human B-2(hB(2)) receptor antagonists. Here we report the in vitro and in vivo BK antagonist activity of a further evolution of the series, consisting in compounds of the general formula 2, containing either an alkyl piperazine or a 4-alkyl piperidine ring bearing various positively charged groups (R'). These studies unexpectedly revealed quite a flat nanomolar/subnanomolar SAR for the binding affinity, while differences were seen in the in vitro functional activities. We propose that variations in the residence time may explain these results. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2012.01.036

文献信息

• 2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPINE DERIVATIVE AND MEDICINAL COMPOSITION
  申请人：Wakamoto Pharmaceutical Co., Ltd.

  公开号：EP1820799A1

  公开（公告）日：2007-08-22

  The present invention has its object to provide a 2,3,4,5-tetrahydro-1H-1,5-benzodiazepine derivative represented with the Formula (1) , or the pharmaceutically acceptable salt, which is effective as a therapeutic and prophylactic agent for diabetes, diabetic nephropathy, or glomerulosclerosis.

  本发明的目的是提供一种用化学式（1）表示的2,3,4,5-四氢-1H-1,5-苯二氮䓬衍生物，或其药学上可接受的盐，作为治疗和预防糖尿病、糖尿病肾病或肾小球硬化的药剂。
• Fused bicyclic amide compounds and medicinal use thereof
  申请人：——

  公开号：US20030203909A1

  公开（公告）日：2003-10-30

  The present invention provides a compound represented by the formula (I) 1 wherein ring A is benzene, cyclohexane, pyridine, piperidine or a derivative thereof, imidazole or a derivative thereof and the like, ring B is benzene, cyclohexane, pyrrole or a derivative thereof, furan, thiophene and the like, R 1 , R 2 and R 3 are each hydrogen, alkyl, halogen, hydroxyl group, alkoxy and the like, W is hydrogen, alkyl or hydroxycarbonylalkyl, X is halogen, cyano, nitro and the like, X′ is hydrogen, halogen and the like, and Y is alkyl, hydroxyalkyl, hydroxycarbonylalkyl, aminoalkyl and the like, a salt thereof, and a pharmaceutical agent containing the compound. The compound of the present invention shows a superior inhibitory effect on the proliferation of activated lymphocyte and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.

  本发明提供了一种由以下化学式（I）1所代表的化合物，其中环A为苯、环己烷、吡啶、哌啶或其衍生物、咪唑或其衍生物等，环B为苯、环己烷、吡咯或其衍生物、呋喃、噻吩等，R1、R2和R3分别为氢、烷基、卤素、羟基、烷氧基等，W为氢、烷基或羟基羰基烷基，X为卤素、氰基、硝基等，X′为氢、卤素等，Y为烷基、羟基烷基、羟基羰基烷基、氨基烷基等，其盐和含有该化合物的药物。本发明的化合物对活化淋巴细胞的增殖具有优越的抑制作用，并可用作各种自身免疫性疾病的预防或治疗剂。
• ALKANOLAMINE, FRICTION-REDUCING AGENT, AND LUBRICATING OIL COMPOSITION
  申请人：TOSOH CORPORATION

  公开号：US20200039942A1

  公开（公告）日：2020-02-06

  To provide a friction-reducing agent containing no sulfur nor phosphorus and being excellent in friction-reducing properties, and a lubricating oil composition using it. An alkanolamine represented by the following formula is used as a friction-reducing agent: wherein A 1 and A 2 are each independently a hydroxy group or a hydrogen atom, provided that A 1 and A 2 are not hydrogen atoms at the same time, R 1 is a hydrocarbon group having at most 30 carbon atoms, R 2 to R 6 are each independently a hydrogen atom or a hydrocarbon group having at most 30 carbon atoms, and m and n are each independently an integer of from 0 to 10.

  提供一种不含硫和磷、在减摩性能方面表现优异的减摩剂，以及使用该减摩剂的润滑油组合物。作为减摩剂使用以下式表示的脂肪胺：其中A1和A2分别独立地是羟基或氢原子，前提是A1和A2不同时是氢原子，R1是最多有30个碳原子的烃基，R2到R6分别独立地是氢原子或最多有30个碳原子的烃基，m和n分别独立地是0到10的整数。
• PROCESS FOR PRODUCING HYDROXYALKYLTRIETHYLENEDIAMINE, AND CATALYST COMPOSITION FOR THE PRODUCTION OF POLYURETHANE RESIN USING IT
  申请人：Tokumoto Katsumi

  公开号：US20110077376A1

  公开（公告）日：2011-03-31

  To provide a process for producing a hydroxyalkyltriethylenediamine or hydroxytriethylenediamine simply and in a small number of steps without requiring multi-stage reaction steps; a novel catalyst composition whereby a polyurethane product can be obtained with good productivity and good moldability without bringing about odor problems or environmental problems; and a process for producing a polyurethane resin using the catalyst composition. For example, a hydroxyalkyltriethylenediamine or hydroxytriethylenediamine is produced by subjecting a mono-substituted dihydroxyalkylpiperazine and/or a di-substituted hydroxyalkylpiperazine to an intramolecular dehydration condensation reaction in the presence of an acid catalyst. Further, for example, a polyurethane resin is produced by using a catalyst composition which comprises a hydroxyalkyltriethylenediamine or hydroxytriethylenediamine (A), and an amine compound (B) having, in its molecule, one or more substituents selected from the group consisting of a hydroxy group, a primary amino group and a secondary amino group, or a tertiary amine compound (C) having a value of [blowing reaction rate constant/gelling reaction rate constant] of at least 0.5.

  提供一种简单且步骤较少的工艺，用于生产羟基烷基三乙烯二胺或羟基三乙烯二胺，而无需进行多级反应步骤；一种新颖的催化剂组合物，可以在不产生异味或环境问题的情况下获得具有良好生产率和良好成型性的聚氨酯产品；以及使用催化剂组合物生产聚氨酯树脂的工艺。例如，通过在酸催化剂存在下，使单取代二羟基烷基哌嗪和/或双取代羟基烷基哌嗪经历分子内脱水缩合反应，可以生产羟基烷基三乙烯二胺或羟基三乙烯二胺。此外，例如，使用催化剂组合物生产聚氨酯树脂，该组合物包括羟基烷基三乙烯二胺或羟基三乙烯二胺（A），以及在其分子中具有一个或多个取代基的胺化合物（B），所述取代基选自羟基、一级胺基和二级胺基的群，或者具有至少0.5的[发泡反应速率常数/凝胶反应速率常数]值的三级胺化合物（C）。
• Thiazolamine Derivative and Use Thereof as Anti-Picornaviral Infection Medicament
  申请人：Li Song

  公开号：US20140080840A1

  公开（公告）日：2014-03-20

  Disclosed is as a substituted thiazolamine derivative represented by Formula I or a pharmaceutically acceptable salt thereof or a hydrate thereof (the definitions of each group in the formula are as presented in the description), and the application thereof in the prevention and/or treatment of viral diseases induced by picornavirus. Also disclosed is a pharmaceutical composition containing the compound.

  本发明涉及一种由式I表示的取代噻唑胺衍生物，或其药学上可接受的盐或水合物（式中每个基团的定义如说明书所述），以及其在预防和/或治疗由小肠病毒引起的病毒性疾病中的应用。同时还公开了一种含有该化合物的药物组合物。